Skip Navigation



JAC Advance Access published online on October 11, 2005
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dki381
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
56/6/1181    most recent
dki381v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Johnson, A. P.
Right arrow Articles by George, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Johnson, A. P.
Right arrow Articles by George, R. C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Correspondence

Susceptibility of pneumococci causing meningitis in England and Wales to first-line antimicrobial agents, 2001-2004

Alan P. Johnson 1*, Nicola Potz 1, Pauline Waight 1, Usha Gungabissoon 2, David M. Livermore 3, Richard Pebody 2, Elizabeth Miller 2, and Robert C. George 4

1 Department of Healthcare-Associated Infection and Antimicrobial Resistance, Health Protection Agency Centre for Infections, London NW9 5EQ, UK
2 Immunisation Department, Health Protection Agency Centre for Infections, London NW9 5EQ, UK
3 Antibiotic Resistance Monitoring and Reference Laboratory, Health Protection Agency Centre for Infections, London NW9 5HT, UK
4 Respiratory and Systemic Infection Laboratory, Health Protection Agency Centre for Infections, London NW9 5HT, UK

* To whom correspondence should be addressed.
Alan P. Johnson, E-mail: alan.johnson{at}hpa.org.uk



This article has no Abstract. Keywords: therapy; surveillance; pneumococcal.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.